Current challenges in pediatric pulmonary hypertension. - Wikidata - awgldk - TriplyDB

Current challenges in pediatric pulmonary hypertension.

Current challenges in pediatric pulmonary hypertension.

http://www.wikidata.org/entity/Q37540613

about

Characteristics of pediatric pulmonary hypertension trials registered on ClinicalTrials.gov.Applying Biotechnology and Bioengineering to Pediatric Lung Disease: Emerging Paradigms and Platforms Non-invasive determination by cardiovascular magnetic resonance of right ventricular-vascular coupling in children and adolescents with pulmonary hypertension.The Post-Anesthetic Care of Pediatric Patients With Pulmonary Hypertension.Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension.The role of inflammatory biomarkers in CHD-associated pulmonary hypertension in children.Pulmonary Hypertension in Children - a Practical Approach.NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis.

P2860

Q33788441-146D96AB-8742-407D-99E3-E0FF258A985D Q35701265-FFCD7C90-3E8B-49EC-A41E-92B3ABA36FC1 Q36070811-5144495F-4EDE-45B1-B6D0-DF59EF2F45F4 Q38541758-A6E8A373-D5D4-4DEA-81D5-B48E2C201E92 Q38896631-9871180E-8C2A-472F-BCB8-60CB9E1CE384 Q39213635-A21D6D97-C547-4723-9D49-3A8446117627 Q41029573-B9068149-5D0C-47C9-9050-F3F464B04D2D Q50458150-F0A8B84C-9987-40D8-8A30-056C2270ED0C

P2860

Current challenges in pediatric pulmonary hypertension.

http://www.wikidata.org/entity/Q37540613

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current challenges in pediatric pulmonary hypertension.

@en

Current challenges in pediatric pulmonary hypertension.

@nl

type

label

Current challenges in pediatric pulmonary hypertension.

@en

Current challenges in pediatric pulmonary hypertension.

@nl

prefLabel

Current challenges in pediatric pulmonary hypertension.

@en

Current challenges in pediatric pulmonary hypertension.

@nl

P1433

Q37540613-4C7DDCE0-F985-46B6-94A0-32D22F5529D3

P1476

Q37540613-E6950B26-49B0-4906-9532-ACB9C7D7124C

P2093

Q37540613-1ED481E6-6504-43DE-8012-98BD7498D3E7

Q37540613-A72047A4-01CC-4900-BE22-4B22ABAB2280

P2860

Q37540613-018BE1C8-E4E7-4537-A88B-C210EB50E59C

Q37540613-0377C2D4-AB96-4B39-ABA2-EECE6AB81D57

Q37540613-03A8ED62-F875-470E-90CA-7524A0B32D52

Q37540613-03DDF423-85DD-4A94-97F2-C22537EF7F2B

Q37540613-04482A95-212A-449B-873D-1653F13D3F20

Q37540613-04724981-FD95-42D9-A9CE-31794A6A8832

Q37540613-05035CA2-02C7-42BC-9E5B-7A162C1BA55E

Q37540613-072ECB89-2B5F-4DCB-BA46-1ECD4C3D376E

Q37540613-0D815AE4-28A8-43E6-9A73-B6EF941D7825

Q37540613-0E7BB63F-BAFC-4BC8-84B2-3202B3811AD5

P304

Q37540613-2103D42B-7CD0-4AEC-A95B-57CF073D5ADD

P31

Q37540613-4C34D9A0-9115-4C27-9111-0136641BD266

P356

Q37540613-9CEC6E2A-9FE7-47FF-9F59-EC77591569AC

P433

Q37540613-12B58A71-1A8E-475E-949A-AB69A35A9F1A

P478

Q37540613-0FA1A0C0-38B1-4C2B-828D-1051DDAA0510

P577

Q37540613-6705C792-06AC-4697-8E79-80318797FD64

P5875

Q37540613-7C9F9A35-C2B6-44B6-986A-E60E158A8A27

P698

Q37540613-71EEB1DC-9F5F-4B98-95F0-99570C37C5A5

P921

Q37540613-132C0B2A-7BBF-4BF2-807D-337A79B15A20

P932

Q37540613-2D1090DE-8521-4A5D-A89E-67893E7D88F0

P356

P1433

Seminars in Respiratory and Critical Care Medicine

P1476

Current challenges in pediatric pulmonary hypertension.

@en

P2093

David Dunbar Ivy

http://www.w3.org/2001/XMLSchema#string

Shinichi Takatsuki

http://www.w3.org/2001/XMLSchema#string

P2860

Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Updated clinical classification of pulmonary hypertension.

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Portopulmonary hypertension in pediatric patients.

Childhood idiopathic pulmonary arterial hypertension: a national cohort study.

Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.

Clinical features of paediatric pulmonary hypertension: a registry study

Initial experience with tadalafil in pediatric pulmonary arterial hypertension.

Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension.

P304

627-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0033-1356461

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256611995

http://www.w3.org/2001/XMLSchema#string

P698

24037630

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3909673

http://www.w3.org/2001/XMLSchema#string